BrightGene Bio-Medical Technology's IPO

BrightGene Bio-Medical Technology raised a round of funding on November 30, 2017. Investors include Public.

BrightGene Bio-Medical Technology (博瑞生物) (NEEQ: 872404) is a biopharmaceutical company that engages in the research, development, and manufacturing of high-value generics, such as complex Acti…

Articles about BrightGene Bio-Medical Technology's IPO: